ANI PHARMACEUTICALS, INC Convertible Notes Payable, Current
ANI PHARMACEUTICALS, INC (ANIP) had Convertible Notes Payable, Current of $1.23 million as of 2011-09-30, per its 10-Q filed 2011-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2012-03-13
- 2011-09-30: Convertible Notes Payable, Current $1.23M.
- 2011-06-30: Convertible Notes Payable, Current $1.19M.
- 2010-12-31: Convertible Notes Payable, Current $1.11M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2011-09-30 | $1.23M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $1.19M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $1.11M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |